Skip to main content
Top
Published in: World Journal of Surgery 2/2014

01-02-2014

Surgical Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis

Authors: Kenneth S. H. Chok, Tan To Cheung, See Ching Chan, Ronnie T. P. Poon, Sheung Tat Fan, Chung Mau Lo

Published in: World Journal of Surgery | Issue 2/2014

Login to get access

Abstract

Background

Different approaches to surgical treatment of portal vein tumor thrombosis (PVTT) have been advocated. This study investigated the outcomes of different surgical approaches in hepatocellular carcinoma (HCC) patients with PVTT.

Methods

We reviewed prospectively collected data for all patients who underwent hepatectomy for HCC at our hospital between December 1989 and December 2010. Patients were excluded from analysis if they had extrahepatic disease, PVTT reaching the level of the superior mesenteric vein, or hepatectomy with a positive resection margin. The remaining patients were divided into three groups for comparison: group 1, with ipsilateral PVTT resected in a hepatectomy; group 2, with PVTT extending to or beyond the portal vein bifurcation, treated by en bloc resection followed by portal vein reconstruction; group 3, with PVTT extending to or beyond the portal vein bifurcation, treated by thrombectomy.

Results

A total of 88 patients, with a median age of 54 years, were included in the analysis. Group 2 patients were younger, with a median age of 43.5 years versus 57 in group 1 and 49 in group 3 (p = 0.017). Group 1 patients had higher preoperative serum alpha-fetoprotein levels, with a median of 8,493 ng/mL versus 63.25 in group 2 and 355 in group 3 (p = 0.004), and shorter operation time, with a median of 467.5 min versus 663.5 in group 2 and 753 in group 3 (p = 0.018). No patient had thrombus in the main portal vein. Two (2.8 %) hospital deaths occurred in group 1 and one (10 %) in group 2, but none in group 3 (p = 0.440). The rates of complication in groups 1, 2, and 3 were 31.9, 50.0, and 71.4 %, respectively (p = 0.079). The median overall survival durations were 10.91, 9.4, and 8.58 months, respectively (p = 0.962), and the median disease-free survival durations were 4.21, 3.78, and 1.51 months, respectively (p = 0.363). The groups also had similar patterns of disease recurrence (intrahepatic: 33.8 vs. 28.6 vs. 40.0 %; extrahepatic: 16.9 vs. 14.3 vs. 0 %; both: 28.2 vs. 42.9 vs. 40.0 %; no recurrence: 21.1 vs. 14.3 vs. 20.0 %; p = 0.836).

Conclusions

The three approaches have similar outcomes in terms of survival, complication, and recurrence. Effective adjuvant treatments need to be developed to counteract the high incidence of recurrence.
Literature
2.
go back to reference El-Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745–750PubMedCrossRef El-Serag HB, Mason AC (1999) Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745–750PubMedCrossRef
3.
go back to reference Fan ST, Lo CM, Liu CL et al (1999) Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229:322–330PubMedCrossRef Fan ST, Lo CM, Liu CL et al (1999) Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229:322–330PubMedCrossRef
4.
go back to reference Colella G, Bottelli R, De Carlis L et al (1998) Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection and chemoembolization. Transpl Int 11(Suppl 1):S193–S196PubMed Colella G, Bottelli R, De Carlis L et al (1998) Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection and chemoembolization. Transpl Int 11(Suppl 1):S193–S196PubMed
5.
go back to reference Fong Y, Sun RL, Jarnagin W et al (1999) An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229:790–800PubMedCrossRef Fong Y, Sun RL, Jarnagin W et al (1999) An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229:790–800PubMedCrossRef
6.
go back to reference Llovet JM, Bustamante J, Castells A et al (1999) Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29:62–67PubMedCrossRef Llovet JM, Bustamante J, Castells A et al (1999) Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology 29:62–67PubMedCrossRef
7.
go back to reference Wu CC, Hsieh SR, Chen JT et al (2000) An appraisal of liver and portal vein resection for hepatocellular carcinoma with tumor thrombi extending to portal bifurcation. Arch Surg 135:1273–1279PubMedCrossRef Wu CC, Hsieh SR, Chen JT et al (2000) An appraisal of liver and portal vein resection for hepatocellular carcinoma with tumor thrombi extending to portal bifurcation. Arch Surg 135:1273–1279PubMedCrossRef
8.
go back to reference Yamaoka Y, Kumada K, Ino K et al (1992) Liver resection for hepatocellular carcinoma with direct removal of tumour thrombi in the main portal vein. World J Surg 16:1171–1176. doi:10.1007/BF02067093 CrossRef Yamaoka Y, Kumada K, Ino K et al (1992) Liver resection for hepatocellular carcinoma with direct removal of tumour thrombi in the main portal vein. World J Surg 16:1171–1176. doi:10.​1007/​BF02067093 CrossRef
9.
go back to reference Tanaka A, Morimoto T, Yamaoka Y (1996) Implications of surgical treatment for advanced hepatocellular carcinoma with tumour thrombi in the portal vein. Hepatogastroenterology 43:637–643PubMed Tanaka A, Morimoto T, Yamaoka Y (1996) Implications of surgical treatment for advanced hepatocellular carcinoma with tumour thrombi in the portal vein. Hepatogastroenterology 43:637–643PubMed
10.
go back to reference Inoue Y, Hasegawa K, Ishizawa T et al (2009) Is there any difference in survival according to the portal tumour thrombectomy method in patients with hepatocellular carcinoma? Surgery 145:9–19PubMedCrossRef Inoue Y, Hasegawa K, Ishizawa T et al (2009) Is there any difference in survival according to the portal tumour thrombectomy method in patients with hepatocellular carcinoma? Surgery 145:9–19PubMedCrossRef
11.
go back to reference Pugh RN, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding varices. Br J Surg 60:646–649PubMedCrossRef Pugh RN, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding varices. Br J Surg 60:646–649PubMedCrossRef
12.
go back to reference Fan ST, Lai EC, Lo CM et al (1995) Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg 130:198–203PubMedCrossRef Fan ST, Lai EC, Lo CM et al (1995) Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg 130:198–203PubMedCrossRef
13.
go back to reference Lau H, Man K, Fan ST et al (1997) Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 84:1255–1259PubMedCrossRef Lau H, Man K, Fan ST et al (1997) Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 84:1255–1259PubMedCrossRef
14.
go back to reference Liu CL, Fan ST, Lo CM et al (2004) Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg 239:194–201PubMedCrossRef Liu CL, Fan ST, Lo CM et al (2004) Abdominal drainage after hepatic resection is contraindicated in patients with chronic liver diseases. Ann Surg 239:194–201PubMedCrossRef
15.
go back to reference Couinaud C, Foi Le (1957) Etudes Anatomiques et Chirugicales. Masson Publishers, Paris, pp 400–409 Couinaud C, Foi Le (1957) Etudes Anatomiques et Chirugicales. Masson Publishers, Paris, pp 400–409
16.
go back to reference Cheung TT, Chan SC, Ho CL et al (2011) Can positron emission tomography with the dual tracers (11 C)acetate and (18 F)fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma? Liver Transpl 17:1218–1225PubMedCrossRef Cheung TT, Chan SC, Ho CL et al (2011) Can positron emission tomography with the dual tracers (11 C)acetate and (18 F)fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma? Liver Transpl 17:1218–1225PubMedCrossRef
17.
go back to reference Poon RT, Fan ST, Lo CM et al (1999) Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 229:216–222PubMedCrossRef Poon RT, Fan ST, Lo CM et al (1999) Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg 229:216–222PubMedCrossRef
18.
go back to reference Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedCrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedCrossRef
19.
go back to reference Kumada K, Ozawa K, Okamoto R et al (1990) Hepatic resection for advanced hepatocellular carcinoma with removal of portal vein tumour thrombi. Surgery 108:821–827PubMed Kumada K, Ozawa K, Okamoto R et al (1990) Hepatic resection for advanced hepatocellular carcinoma with removal of portal vein tumour thrombi. Surgery 108:821–827PubMed
20.
go back to reference Ohkubo T, Yamamoto J, Sugawara Y et al (2000) Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. J Am Coll Surg 191:657–660PubMedCrossRef Ohkubo T, Yamamoto J, Sugawara Y et al (2000) Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. J Am Coll Surg 191:657–660PubMedCrossRef
21.
go back to reference Konishi M, Ryu M, Kinoshita T et al (2001) Surgical treatment of hepatocellular carcinoma with direct removal of the tumor thrombus in the main portal vein. Hepatogastroenterology 48:1421–1424PubMed Konishi M, Ryu M, Kinoshita T et al (2001) Surgical treatment of hepatocellular carcinoma with direct removal of the tumor thrombus in the main portal vein. Hepatogastroenterology 48:1421–1424PubMed
22.
go back to reference Pawlik TM, Poon RT, Abdalla EK et al (2005) Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 137:403–410PubMedCrossRef Pawlik TM, Poon RT, Abdalla EK et al (2005) Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 137:403–410PubMedCrossRef
23.
go back to reference Chen XP, Qiu FZ, Wu ZD et al (2006) Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma. Ann Surg Oncol 13:940–946PubMedCrossRef Chen XP, Qiu FZ, Wu ZD et al (2006) Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma. Ann Surg Oncol 13:940–946PubMedCrossRef
24.
go back to reference Ikai I, Hatano E, Hasegawa S et al (2006) Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein. J Am Coll Surg 202:431–438PubMedCrossRef Ikai I, Hatano E, Hasegawa S et al (2006) Prognostic index for patients with hepatocellular carcinoma combined with tumor thrombosis in the major portal vein. J Am Coll Surg 202:431–438PubMedCrossRef
25.
go back to reference Le Treut YP, Hardwigsen J, Ananian P et al (2006) Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature: a European case-control series. J Gastrointest Surg 10:855–862PubMedCrossRef Le Treut YP, Hardwigsen J, Ananian P et al (2006) Resection of hepatocellular carcinoma with tumor thrombus in the major vasculature: a European case-control series. J Gastrointest Surg 10:855–862PubMedCrossRef
26.
go back to reference Chan SC, Liu CL, Lo CM et al (2003) Value of live donor liver transplantation experience in major hepatectomy for hepatocellular carcinoma. Arch Surg 138:265–271PubMedCrossRef Chan SC, Liu CL, Lo CM et al (2003) Value of live donor liver transplantation experience in major hepatectomy for hepatocellular carcinoma. Arch Surg 138:265–271PubMedCrossRef
27.
go back to reference Li Q, Wang J, Sun Y et al (2006) Efficacy of postoperative transarterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma complicated by portal vein tumor thrombosis—a randomized study. World J Surg 30:2004–2011. doi:10.1007/s00268-006-0271-6 PubMedCrossRef Li Q, Wang J, Sun Y et al (2006) Efficacy of postoperative transarterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma complicated by portal vein tumor thrombosis—a randomized study. World J Surg 30:2004–2011. doi:10.​1007/​s00268-006-0271-6 PubMedCrossRef
Metadata
Title
Surgical Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis
Authors
Kenneth S. H. Chok
Tan To Cheung
See Ching Chan
Ronnie T. P. Poon
Sheung Tat Fan
Chung Mau Lo
Publication date
01-02-2014
Publisher
Springer US
Published in
World Journal of Surgery / Issue 2/2014
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-013-2290-4

Other articles of this Issue 2/2014

World Journal of Surgery 2/2014 Go to the issue